Chartwell Molecular

APR 8, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Levetiracetam Solution (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval for labeling change to an established generic antiepileptic; does not contain clinical trial data or efficacy evidence.